Ayed Y. Asiri

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · Trials · 2020 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · New England Journal of Medicine · 2020 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Faizah Alotaibi, Naif Khalaf Alharbi, Lindsey B. Rosen et al. · Influenza and Other Respiratory Viruses · 2023 · 47 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients

Ayodele Alaiya, Abeer N. Alshukairi, Zakia Shinwari et al. · Journal of Inflammation Research · 2021 · 22 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans

Amin Addetia, Cameron Stewart, Albert J. Seo et al. · Cell Reports · 2024 · 21 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17